Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter, Single-blind Trial to Assess the Safety and Effectiveness of the Encompass F2 Cerebral Protection System Vs. Standard of Care (Unprotected or Sentinel® Cerebral Protection System) During Transfemoral Transcatheter Aortic Valve Replacement

NCT06689839 is registered in ClinicalTrials.gov with EnCompass Technologies, Inc. as lead sponsor.

NCT NCT06689839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06689839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter, Single-blind Trial to Assess the Safety and Effectiveness of the Encompass F2 Cerebral Protection System Vs. Standard of Care (Unprotected or Sentinel® Cerebral Protection System) During Transfemoral Transcatheter Aortic Valve Replacement
Lead sponsor
EnCompass Technologies, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 9, 2025
Completion date
January 31, 2027
Enrollment
500 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

aortic diseases, aortic stenosis treated with tavi